Themes
Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit
Study shows patients taking abatacept, cenicriviroc, or Remicade in addition to SOC do not recover quicker compared to placebo.
Corporate sustainability needs ESG standards and tools
Invivyd doses first patient in Covid-19 therapy trial
Is long Covid linked to Alzheimer’s disease?
Tonix’s PREVAIL study fails to meet pre-specified primary endpoint
DVCR partners with Clario to provide cardiac data in trials
